Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine. J Infect Dis, 212, 525-530. presented at the 08/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25712967. (2015).
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons >/=18 Years Old. J Infect Dis, 212, 552-561. presented at the 08/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25649171. (2015).
Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals. Vaccine, 32, 2732-2739. presented at the 05/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24607004. (2014).
Safety and Immunological Outcomes Following Human Inoculation with Nontypeable Haemophilus Influenzae. J Infect Dis, 208, 728-738. presented at the 09/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23715660. (2013).
Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009. Vaccine, 13, 4240-4248. presented at the 06/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=22537984. (2012).
Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations. J Infect Dis, 206, 828-837. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=22802432. (2012).
Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults. Vaccine, 29, 5666-5674. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21699951. (2011).
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine. J Amer Med Assn, 292, 1205-1212. presented at the 2004.. (2004).